Ryanodex, dantrolene sodium - Dantrolene sodium 250 mg / 5mL Injection 20 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 42367-0540-32 |
|---|---|
| Product NDC | 42367-0540 |
| Generic Drug Name | dantrolene sodium |
| Brand Name | Ryanodex, dantrolene sodium |
| Manufacturer | Eagle Pharmaceuticals, Inc. |
| Strength | 250 mg / 5mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial |
| Package Description | 1 VIAL in 1 CARTON (42367-540-32) / 20 mL in 1 VIAL |
| Active Ingredients | Dantrolene Sodium |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
dantrolene sodium 250 mg / 5mL Injection is tracked under NDC 42367-0540-32 and rolls up into product family 42367-0540. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Vial.
- Manufacturer: Eagle Pharmaceuticals, Inc..
- Dosage form: Injection.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
This NDC has appeared in documented shortage listings more than once since 2022, a repeat pattern that suggests elevated future supply risk.
Drug Shortage Index family
View Dantrolene sodium in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Dantrolene sodium.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Ryanodex, dantrolene sodium - Dantrolene sodium 250 mg / 5mL Injection 20 mL, NDC 42367-0540-32, is a Eagle Pharmaceuticals, Inc. 250 mg / 5mL injection presentation packaged as 1 Vial. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 42367-0540-32
- Digits-only NDC 11: 42367054032
- Possible 10-digit display format: 42367-540-32 (4236754032)
Helpful product links
- Search by brand name: Ryanodex, dantrolene sodium
- NDC 11: 42367-0540-32
- Product family NDC: 42367-0540
- VA classification code: MS200
- VA classification code description: SKELETAL MUSCLE RELAXANTS
- CMOP ID: D1039
- VUID: 4033609